Beranda › Fibrosis Kistik › Michigan
Uji klinis Fibrosis Kistik di Michigan
7 studi untuk Fibrosis Kistik mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
Phase 2 Study to Assess the Safety and Efficacy of ANG003
- University of Michigan, Michigan Medicine, Ann Arbor
- Wayne State University Harper University Hospital, Detroit
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07450547Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
- University of Michigan Health System, Ann Arbor
Menerima peserta
Usia 3 hingga 18 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06654752Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
- University of Michigan, Michigan Medicine, Ann Arbor
- Helen DeVos Children's Hospital, Grand Rapids
Menerima pesertaStudi observasional
Hingga usia 10 · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT04509050Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- University of Michigan, Michigan Medicine, Ann Arbor
- Helen DeVos Children's Hospital, Grand Rapids
Menerima pesertaFase 4
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT05548283Health Outcomes of Parents With Cystic Fibrosis-Aim 2
- University of Michigan, Ann Arbor
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Nov 2025 · NCT06296394Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
- University of Michigan, Ann Arbor
Menerima pesertaStudi observasional
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 3 Nov 2025 · NCT06683092A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
- University of Michigan, Michigan Medicine, Ann Arbor
- Wayne State University Harper University Hospital, Detroit
- Corewell Health Helen DeVos, Grand Rapids
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2025 · NCT06504589Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.